ORLANDO, FLA. — Increasing levels of protein and fiber, stressing portion control, and adding savory flavors are ways that ...
Manufacturers such as Nestle have responded, debuting its Vital Pursuit brand specifically designed to support GLP-1 consumer diets. The frozen food products initially launched in September and ...
The Food and Drug Administration on Friday announced that semaglutide, the active ingredient in weight loss drugs Ozempic and ...
The rise in GLP-1 drugs is undeniable. Morgan Stanley projects that by 2035, 24 million Americans, or 7% of the population, will be using these medications. But that estimate may ...
A recent study from Cornell University and consumer-insights group Numerator looked at food spending habits of 150,000 U.S. households with at least one GLP-1 drug user between July 2022 through ...
Ryals McMullian noted consumers are moving away from traditional white and wheat bread into organic, keto, gluten-free and ...
12d
GlobalData on MSNFlowers Foods eyes GLP-1 effect as bread category weakness hits salesFlowers has documented for several quarters a consumer shift away from traditional loaves toward more “differentiated and ...
Although the first GLP-1 drug was approved by the US Food and Drug Administration (FDA) in the early 2000s, it wasn't until a ...
A new clinical trial showed promising results in curbing alcohol cravings in individuals with moderate alcohol-use disorder.
Eli Lilly continues to see strong growth coming from its GLP-1 drugs. The company's current 2025 guidance looks conservative.
GLP-1 medications initially were used to help people with diabetes improve their insulin resistance and hunger cravings.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results